A phase II study of E7070 [indisulam] in patients with progressive inoperable and/or metastatic renal cell carcinoma.
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2009
At a glance
- Drugs Indisulam (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- 10 Sep 2009 Actual end date (1 Dec 2003) added as reported by ClinicalTrials.gov.
- 18 Sep 2005 New trial record.